- The Campus2Corporate Program (C2CP) is part of Cadila Pharmaceuticals’ CADi-SHIL initiative, which symbolizes the perfect blend of Cadila’s industry expertise with Indrashil University’s academic excellence
- Entrance Test (CPAT): 9th November 2024
- Mode: Online
- Program Commencement: 18th November, 2024
NE EDUCATION BUREAU
AHMEDABAD, OCT 2
Cadila Pharmaceuticals Limited, a global leader in pharmaceuticals, has announced an exciting new collaboration with Indrashil University (IU) to introduce the Campus2Corporate Program (C2CP).
This tailor-made Executive Diploma in Pharma Field Operations course is designed to bridge the gap between academic learning and corporate demands, providing aspiring professionals with the skills and insights necessary for a thriving career in the pharmaceutical industry.
In today’s competitive pharmaceutical landscape, there is often a disconnect between theoretical knowledge gained in academic settings and the practical demands of corporate environments. The Campus2Corporate Program (C2CP) is created to address this very challenge. The program is specifically designed to equip students with a deep understanding of real-world pharmaceutical practices, preparing them for the complexities they will face in professional roles. By offering a curriculum that integrates both academic knowledge and industry-specific insights, the C2CP enables participants to seamlessly transition from university life to a thriving career in the corporate pharmaceutical sector. Graduates will not only gain an Executive Diploma but also the essential skills needed to adapt to fast-evolving industry trends, regulations, and innovations, making them highly sought-after professionals in the pharma world.
“At Indrashil University, we are committed to bridging the gap between academia and industry. The Campus2Corporate Program is a significant step in that direction, providing students with the practical skills and corporate insights essential for success in the ever-evolving pharmaceutical sector. This collaboration with Cadila Pharmaceuticals will create a new benchmark for industry-ready professionals,” said Dr. Dharmesh J. Shah (PhD), Provost (Vice Chancellor), Indrashil University.
The C2CP Program
The C2CP program is an industry-first initiative aimed at preparing students and young professionals to navigate the dynamic landscape of the pharma sector. By combining the academic rigor of Indrashil University with the corporate expertise of Cadila Pharmaceuticals, the program provides hands-on experience, industry-specific training, and practical knowledge to equip participants for real-world challenges in pharma.
Participants in the program will have access to:
- Practical Insights into the pharmaceutical industry from leading experts at Cadila Pharmaceuticals.
- Industry-Specific Skills to meet the evolving demands of the healthcare and pharmaceutical sectors.
- Executive Diploma Certification, jointly awarded by Cadila Pharmaceuticals and Indrashil University, making it a prestigious qualification in the industry.
- Career Pathway: Cadila Pharmaceuticals will offer career opportunities for outstanding performers in the program, providing a seamless transition from Campus to Corporate.
- Employability Aspect – This will be “An Employability Enabling Course” and the course material, methods and techniques will guide the joiners for better employability aspects within Cadila Pharmaceuticals subject to successful course completion with required standards.
The CADi-SHIL Initiative
The Campus2Corporate Program (C2CP) is part of Cadila Pharmaceuticals’ CADi-SHIL initiative, which symbolizes the perfect blend of Cadila’s industry expertise with Indrashil University’s academic excellence. This initiative seeks to empower the next generation of pharma professionals by offering them a robust and immersive educational experience that aligns with current industry trends and expectations.
Indrashil University
Indrashil University is renowned for its strong research orientation and a commitment to producing the leaders of tomorrow. With a cutting-edge curriculum and state-of-the-art facilities, IU fosters innovation and excellence in the pharmaceutical and healthcare sectors.
Key Dates & Information
- Entrance Test (CPAT): 9th November 2024
- Mode: Online
- Program Commencement: 18th November, 2024
- For more information and to apply: https://www.cadilapharma.com/campus-to-corporate-program/
Through this strategic collaboration, Cadila Pharmaceuticals and Indrashil University aim to nurture a new generation of skilled pharma professionals, shaping the future of the healthcare industry. Apply today to be a part of this transformational journey from campus to corporate.
